2m 2m 2m 2m 2m 2m 2m
BIOAFFINITY (BIAF)
NASDAQ
$2.46+$0.03 (+1.24%)
Price as of Nov 12, 2026 8:57 AM EST- $3.1MMarket Cap
- -92.48%1-Year Change
- Diagnostics & ResearchIndustry
BIOAFFINITY (BIAF)
$2.46+$0.03 (+1.24%)
BIAF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.42 | ||
Change | +$0.03 (+1.46%) | ||
Open | $2.37 | ||
High | $2.60 | ||
Low | $2.23 | ||
Previous Close | $2.39 | ||
Volume | 76,416 | ||
30-Day Average Volume | 148,437 | ||
1-Week Change | -17.24% | ||
1-Month Change | -48.68% | ||
1-Year Change | -92.48% | ||
3-Year Change | -99.63% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.8M | ||
Total Assets | $7.6M | ||
Market Cap | $3.1M | ||
Enterprise Value | $740,326.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$3.9M | ||
EBIT | $0.00 | ||
EBITDA | $66,842.00 | ||
Net Working Capital | $1.3M | ||
EPS | -$5.89 | ||
Enterprise Value/EBITDA | 11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 08/24/2026 | ||
Earnings & Revenue